US 10428070
Hepatitis B antiviral agents
granted A61KA61K45/06A61P
Quick answer
US patent 10428070 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K45/06, A61P, A61P31/14